Armata Pharmaceuticals (ARMP) Cash from Investing Activities Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.71% |
| Dec 31, 2025 | 32.31% |
| Sep 30, 2025 | -24.47% |
| Jun 30, 2025 | 11.41% |
| Mar 31, 2025 | 0.98% |
| Dec 31, 2024 | 1.35% |
| Sep 30, 2024 | -48.54% |
| Jun 30, 2024 | -19.86% |
| Mar 31, 2024 | -11.98% |
| Dec 31, 2023 | -34.90% |
| Sep 30, 2023 | -216.83% |
| Dec 31, 2022 | 93.71% |
| Sep 30, 2022 | -108.30% |
| Jun 30, 2022 | -255.52% |
| Mar 31, 2022 | -116.17% |
| Dec 31, 2021 | -77.34% |
| Sep 30, 2021 | -82.18% |
| Jun 30, 2021 | -9.41% |
| Mar 31, 2021 | -21.62% |
| Dec 31, 2020 | -48.90% |
| Sep 30, 2020 | 6.93% |
| Jun 30, 2020 | -97.87% |
| Mar 31, 2020 | -24.33% |
| Dec 31, 2019 | 74.97% |
| Sep 30, 2019 | 19.87% |
| Jun 30, 2019 | 40.46% |
| Mar 31, 2019 | 9.12% |
| Dec 31, 2018 | -154.61% |
| Sep 30, 2018 | 19.23% |